128 related articles for article (PubMed ID: 2096993)
21. Progesterone receptor involvement in independent tumor growth in MPA-induced murine mammary adenocarcinomas.
Montecchia MF; Lamb C; Molinolo AA; Luthy IA; Pazos P; Charreau E; Vanzulli S; Lanari C
J Steroid Biochem Mol Biol; 1999 Jan; 68(1-2):11-21. PubMed ID: 10215033
[TBL] [Abstract][Full Text] [Related]
22. Ethanol induces transient arrest of cell division (G2 + M block) followed by G0/G1 block: dose effects of short- and longer-term ethanol exposure on cell cycle and cell functions.
Mikami K; Haseba T; Ohno Y
Alcohol Alcohol; 1997; 32(2):145-52. PubMed ID: 9105508
[TBL] [Abstract][Full Text] [Related]
23. Onapristone (ZK299) and mifepristone (RU486) regulate the messenger RNA and protein expression levels of the progesterone receptor isoforms A and B in the bovine endometrium.
Rekawiecki R; Kowalik MK; Kotwica J
Theriogenology; 2015 Aug; 84(3):348-57. PubMed ID: 25976976
[TBL] [Abstract][Full Text] [Related]
24. Progesterone receptor antagonism inhibits progestogen-related carcinogenesis and suppresses tumor cell proliferation.
Lee O; Choi MR; Christov K; Ivancic D; Khan SA
Cancer Lett; 2016 Jul; 376(2):310-7. PubMed ID: 27080304
[TBL] [Abstract][Full Text] [Related]
25. NC381, a novel anticancer agent, arrests the cell cycle in G0-G1 and inhibits lung tumor cell growth in vitro and in vivo.
Cao MY; Lee Y; Feng NP; Al-Qawasmeh RA; Viau S; Gu XP; Lau L; Jin H; Wang M; Vassilakos A; Wright JA; Young AH
J Pharmacol Exp Ther; 2004 Feb; 308(2):538-46. PubMed ID: 14610220
[TBL] [Abstract][Full Text] [Related]
26. Regulation of cell growth of a progestin-dependent murine mammary carcinoma in vitro: progesterone receptor involvement in serum or growth factor-induced cell proliferation.
Lamb C; Simian M; Molinolo A; Pazos P; Lanari C
J Steroid Biochem Mol Biol; 1999; 70(4-6):133-42. PubMed ID: 10622401
[TBL] [Abstract][Full Text] [Related]
27. Non-competitive anti-oestrogenic actions of progesterone antagonists in primate endometrium: enhancement of oestrogen and progesterone receptors with blockade of post-receptor proliferative mechanisms.
Neulen J; Williams RF; Breckwoldt M; Chwalisz K; Baulieu EE; Hodgen GD
Hum Reprod; 1996 Jul; 11(7):1533-7. PubMed ID: 8671500
[TBL] [Abstract][Full Text] [Related]
28. Reduction of the intake of food and water is responsible for reduction of litter growth when dams are treated with a progesterone antagonist.
van der Schoot P; Zeegers TA; Muskiet FA; Slappendel EJ
Br J Nutr; 1991 Jul; 66(1):17-26. PubMed ID: 1931902
[TBL] [Abstract][Full Text] [Related]
29. Novel 19-nor-hexafluoride vitamin D3 analog (Ro 25-6760) inhibits human colon cancer in vitro via apoptosis.
Evans SR; Soldatenkov V; Shchepotin EB; Bogrash E; Shchepotin IB
Int J Oncol; 1999 May; 14(5):979-85. PubMed ID: 10200351
[TBL] [Abstract][Full Text] [Related]
30. Hormone concentrations and ovulatory response in rats treated with antiprogestagens.
Uilenbroek JT
J Endocrinol; 1991 Jun; 129(3):423-9. PubMed ID: 2066697
[TBL] [Abstract][Full Text] [Related]
31. Modulatory actions of the new antiprogestins ZK 98.299 and ZK 98.734 and of RU 486 on luteinizing hormone secretion and progesterone effects in pituitary gonadotrophs.
Ortmann O; Hansemann K; Knuppen R; Emons G
J Steroid Biochem; 1990 Aug; 36(5):431-7. PubMed ID: 2214762
[TBL] [Abstract][Full Text] [Related]
32. Effect of two antiprogestins (mifepristone and onapristone) on endometrial factors of potential importance for implantation.
Cameron ST; Critchley HO; Buckley CH; Kelly RW; Baird DT
Fertil Steril; 1997 Jun; 67(6):1046-53. PubMed ID: 9176442
[TBL] [Abstract][Full Text] [Related]
33. Metapristone (RU486 derivative) inhibits cell proliferation and migration as melanoma metastatic chemopreventive agent.
Zheng N; Chen J; Liu W; Wang J; Liu J; Jia L
Biomed Pharmacother; 2017 Jun; 90():339-349. PubMed ID: 28376402
[TBL] [Abstract][Full Text] [Related]
34. Stimulation of mammary tumourigenesis and inhibition of uterine adenomyosis by suppressed progesterone effects in SHN mice.
Nagasawa H; Aoki M; Mori T; Yamamoto K; Inaba T; Mori J
Anticancer Res; 1989; 9(4):827-32. PubMed ID: 2817809
[TBL] [Abstract][Full Text] [Related]
35. Androgen-like and anti-androgen-like effects of antiprogestins in human mammary cancer cells.
Hackenberg R; Hannig K; Beck S; Schmidt-Rhode P; Scholz A; Schulz KD
Eur J Cancer; 1996 Apr; 32A(4):696-701. PubMed ID: 8695275
[TBL] [Abstract][Full Text] [Related]
36. Antiprogestin-progesterone interactions.
Michna H; Fritzemeier KH; Parczyk K; Nishino Y; Schneider MR
Cancer Treat Res; 1996; 83():191-212. PubMed ID: 8826648
[No Abstract] [Full Text] [Related]
37. 11 beta-substituted 13 beta-ethyl gonane derivatives exhibit reversal of antiprogestational activity.
Rao PN; Cessac JW; Blye RP; Kim HK
Steroids; 1998 Jan; 63(1):50-7. PubMed ID: 9437795
[TBL] [Abstract][Full Text] [Related]
38. Antagonist-occupied human progesterone B-receptors activate transcription without binding to progesterone response elements and are dominantly inhibited by A-receptors.
Tung L; Mohamed MK; Hoeffler JP; Takimoto GS; Horwitz KB
Mol Endocrinol; 1993 Oct; 7(10):1256-65. PubMed ID: 8123133
[TBL] [Abstract][Full Text] [Related]
39. Estrogen receptor-negative/progesterone receptor-positive Evsa-T mammary tumor cells: a model for assessing the biological property of this peculiar phenotype of breast cancers.
Borras M; Lacroix M; Legros N; Leclercq G
Cancer Lett; 1997 Nov; 120(1):23-30. PubMed ID: 9570382
[TBL] [Abstract][Full Text] [Related]
40. Effects of antiprogestins RU486 and ZK98299 on the expression of cell cycle proteins of a medroxyprogesterone acetate (MPA)-induced murine mammary tumor.
Peters MG; Vanzulli S; Elizalde PV; Charreau EH; Goin MM
Oncol Rep; 2001; 8(2):445-9. PubMed ID: 11182072
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
